254 related articles for article (PubMed ID: 33846866)
21. Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people.
Myrick H; Anton RF; Li X; Henderson S; Randall PK; Voronin K
Arch Gen Psychiatry; 2008 Apr; 65(4):466-75. PubMed ID: 18391135
[TBL] [Abstract][Full Text] [Related]
22. Cue reactivity and opioid blockade in amphetamine dependence: A randomized, controlled fMRI study.
Guterstam J; Jayaram-Lindström N; Berrebi J; Petrovic P; Ingvar M; Fransson P; Franck J
Drug Alcohol Depend; 2018 Oct; 191():91-97. PubMed ID: 30096639
[TBL] [Abstract][Full Text] [Related]
23. A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence.
Gual A; He Y; Torup L; van den Brink W; Mann K;
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1432-42. PubMed ID: 23562264
[TBL] [Abstract][Full Text] [Related]
24. Effects of extended-release naltrexone on the brain response to drug-related stimuli in patients with opioid use disorder.
Shi Z; Wang AL; Jagannathan K; Fairchild VP; O'Brien CP; Childress AR; Langleben DD
J Psychiatry Neurosci; 2018 Jul; 43(4):254-261. PubMed ID: 29947607
[TBL] [Abstract][Full Text] [Related]
25. A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder.
Kohno M; Dennis LE; McCready H; Schwartz DL; Hoffman WF; Korthuis PT
Drug Alcohol Depend; 2018 Nov; 192():186-192. PubMed ID: 30266003
[TBL] [Abstract][Full Text] [Related]
26. Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment-Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline.
Miranda R; O'Malley SS; Treloar Padovano H; Wu R; Falk DE; Ryan ML; Fertig JB; Chun TH; Muvvala SB; Litten RZ
Alcohol Clin Exp Res; 2020 Jul; 44(7):1431-1443. PubMed ID: 32363592
[TBL] [Abstract][Full Text] [Related]
27. Sodium oxybate plus nalmefene for the treatment of alcohol use disorder: A case series.
Caputo F; Maremmani AG; Addolorato G; Domenicali M; Zoli G; D'Amore A; Maremmani I; Bernardi M
J Psychopharmacol; 2016 Apr; 30(4):402-9. PubMed ID: 26860331
[TBL] [Abstract][Full Text] [Related]
28. Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate.
Palpacuer C; Duprez R; Huneau A; Locher C; Boussageon R; Laviolle B; Naudet F
Addiction; 2018 Feb; 113(2):220-237. PubMed ID: 28940866
[TBL] [Abstract][Full Text] [Related]
29. Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers.
Drobes DJ; Anton RF; Thomas SE; Voronin K
Alcohol Clin Exp Res; 2004 Sep; 28(9):1362-70. PubMed ID: 15365307
[TBL] [Abstract][Full Text] [Related]
30. Purpose in life, neural alcohol cue reactivity and daily alcohol use in social drinkers.
Kang Y; Cosme D; Lydon-Staley D; Ahn J; Jovanova M; Corbani F; Lomax S; Stanoi O; Strecher V; Mucha PJ; Ochsner K; Bassett DS; Falk EB
Addiction; 2022 Dec; 117(12):3049-3057. PubMed ID: 35915548
[TBL] [Abstract][Full Text] [Related]
31. Neuroimaging findings from an experimental pharmacology trial of naltrexone in heavy drinkers of East Asian descent.
Lim AC; Ghahremani DG; Grodin EN; Green R; Bujarski S; Hartwell EE; Courtney KE; Hutchison K; Miotto K; Ray LA
Drug Alcohol Depend; 2019 Jul; 200():181-190. PubMed ID: 31160146
[TBL] [Abstract][Full Text] [Related]
32. Effects of alcohol availability, access to alcohol, and naltrexone on self-reported craving and patterns of drinking in response to an alcohol-cue availability procedure.
Kruse MI; Radnovich AJ; Kalapatapu RK; Mehdiyoun N; Chambers RA; Davidson D
J Stud Alcohol Drugs; 2012 Mar; 73(2):205-15. PubMed ID: 22333328
[TBL] [Abstract][Full Text] [Related]
33. Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene.
Mann K; Bladström A; Torup L; Gual A; van den Brink W
Biol Psychiatry; 2013 Apr; 73(8):706-13. PubMed ID: 23237314
[TBL] [Abstract][Full Text] [Related]
34. Oxytocin modulates alcohol-cue induced functional connectivity in the nucleus accumbens of social drinkers.
Bach P; Reinhard I; Bühler S; Vollstädt-Klein S; Kiefer F; Koopmann A
Psychoneuroendocrinology; 2019 Nov; 109():104385. PubMed ID: 31362183
[TBL] [Abstract][Full Text] [Related]
35. Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.
Schacht JP; Anton RF; Voronin KE; Randall PK; Li X; Henderson S; Myrick H
Neuropsychopharmacology; 2013 Feb; 38(3):414-22. PubMed ID: 23032071
[TBL] [Abstract][Full Text] [Related]
36. G-CuP: the effect of a forced oral glucose intake on alcohol craving and mesolimbic cue reactivity in alcohol dependence-study protocol of a randomized, double-blind, placebo-controlled crossover study.
Wetzel L; Pourbaix M; Riegler A; Pfeifer AM; Reinhard I; Hoffmann S; Vollstädt-Klein S; Kiefer F; Sommer W; Bumb JM; Bach P; Koopmann A
Trials; 2022 Aug; 23(1):693. PubMed ID: 35986409
[TBL] [Abstract][Full Text] [Related]
37. Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers.
Grodin EN; Burnette EM; Green R; Lim AC; Miotto K; Ray LA
Drug Alcohol Depend; 2021 Aug; 225():108825. PubMed ID: 34175784
[TBL] [Abstract][Full Text] [Related]
38. Real-time functional magnetic resonance imaging neurofeedback can reduce striatal cue-reactivity to alcohol stimuli.
Kirsch M; Gruber I; Ruf M; Kiefer F; Kirsch P
Addict Biol; 2016 Jul; 21(4):982-92. PubMed ID: 26096546
[TBL] [Abstract][Full Text] [Related]
39. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
[TBL] [Abstract][Full Text] [Related]
40. Pain Catastrophizing Is Associated With Increased Alcohol Cue-Elicited Neural Activity Among Individuals With Alcohol Use Disorder.
Nieto SJ; Grodin EN; Burnette EM; Cahill CM; Ray LA
Alcohol Alcohol; 2022 Nov; 57(6):727-733. PubMed ID: 35788255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
